We are pleased to have co-led Star Therapeutics' $200 million financing to support Star as it advances its pipeline of new therapies for patients with significant unmet medical needs. Carl Gordon, Managing Partner, said it best, “I have worked with this team across three different companies, and have seen firsthand their ability to identify important therapeutic opportunities and translate them into medicines with the potential to make an impact for patients. We believe Star has the team, scientific approach, and pipeline to build on those achievements in its next phase of growth.” Congrats to the team on this achievement!
star-therapeutics.com/star-therapeut…
star-therapeutics.com/star-therapeut…